Clinical Research

DSPE is conducting clinical development projects within DSP’s prioritised areas of research in the therapeutic areas of central nervous system (CNS), diabetes/cardiovascular and inflammation/allergy. Learn more about our global pipeline.

The Company has significant expertise in developing treatments for various CNS disorders, including schizophrenia, anxiety disorder, epilepsy, and Parkinson's disease.

With the development of DSP's late-stage candidate for the treatment of schizophrenia, DSP aims to extend its experience, commitment, and vision worldwide.

Learn more about clinical trials.